McKesson Corp (MCK) stock
MCKNYSEWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends March 31
Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 16/3027% above fair value
$1091.67−13.37 (-1.21%)
Close on Nov 17, 2026Market cap $127.28BP/E 29.2Yield 0.29%
McKesson operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
McKesson's operating cash flow for the twelve months ending Jun 30, 2026 was $6.85B, up 4.7% year over year. For fiscal 2026 it was $6.16B, up 1.2% from the year before. Over ten years it grew 5.3% a year on average. The highest annual figure on record is $6.16B in fiscal 2026.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Mar 31, 2026 | $6.16B | +1.2% |
| FY2025 | Mar 31, 2025 | $6.09B | +41.1% |
| FY2024 | Mar 31, 2024 | $4.31B | -16.4% |
| FY2023 | Mar 31, 2023 | $5.16B | +16.4% |
| FY2022 | Mar 31, 2022 | $4.43B | -2.4% |
| FY2021 | Mar 31, 2021 | $4.54B | +3.8% |
| FY2020 | Mar 31, 2020 | $4.37B | +8.4% |
| FY2019 | Mar 31, 2019 | $4.04B | -7.1% |
| FY2018 | Mar 31, 2018 | $4.35B | -8.4% |
| FY2017 | Mar 31, 2017 | $4.74B | +29.2% |
| FY2016 | Mar 31, 2016 | $3.67B | +18.0% |
| FY2015 | Mar 31, 2015 | $3.11B | -0.8% |
| FY2014 | Mar 31, 2014 | $3.14B | +26.3% |
| FY2013 | Mar 31, 2013 | $2.48B | -15.8% |
| FY2012 | Mar 31, 2012 | $2.95B | +26.2% |
| FY2011 | Mar 31, 2011 | $2.34B | +0.9% |
| FY2010 | Mar 31, 2010 | $2.32B | +71.4% |
| FY2009 | Mar 31, 2009 | $1.35B | +55.5% |
| FY2008 | Mar 31, 2008 | $869.00M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2027CQ2 2026 | Jun 30, 2026 | -$220.00M | – |
| Q4 FY2026CQ1 2026 | Mar 31, 2026 | $3.42B | -55.8% |
| Q3 FY2026CQ4 2025 | Dec 31, 2025 | $1.23B | – |
| Q2 FY2026CQ3 2025 | Sep 30, 2025 | $2.42B | +15.2% |
| Q1 FY2026CQ2 2025 | Jun 30, 2025 | -$918.00M | – |
| Q4 FY2025CQ1 2025 | Mar 31, 2025 | $7.75B | +86.8% |
| Q3 FY2025CQ4 2024 | Dec 31, 2024 | -$2.38B | -1038.2% |
| Q2 FY2025CQ3 2024 | Sep 30, 2024 | $2.10B | +117.6% |
| Q1 FY2025CQ2 2024 | Jun 30, 2024 | -$1.38B | – |
| Q4 FY2024CQ1 2024 | Mar 31, 2024 | $4.15B | +24.7% |
| Q3 FY2024CQ4 2023 | Dec 31, 2023 | $254.00M | -84.8% |
| Q2 FY2024CQ3 2023 | Sep 30, 2023 | $965.00M | -12.8% |
| Q1 FY2024CQ2 2023 | Jun 30, 2023 | -$1.05B | – |
| Q4 FY2023CQ1 2023 | Mar 31, 2023 | $3.33B | +15.2% |
| Q3 FY2023CQ4 2022 | Dec 31, 2022 | $1.67B | +21.1% |
| Q2 FY2023CQ3 2022 | Sep 30, 2022 | $1.11B | -38.2% |
| Q1 FY2023CQ2 2022 | Jun 30, 2022 | -$941.00M | – |
| Q4 FY2022CQ1 2022 | Mar 31, 2022 | $2.89B | -14.3% |
| Q3 FY2022CQ4 2021 | Dec 31, 2021 | $1.38B | +13.5% |
| Q2 FY2022CQ3 2021 | Sep 30, 2021 | $1.79B | +75.5% |
| Q1 FY2022CQ2 2021 | Jun 30, 2021 | -$1.62B | – |
| Q4 FY2021CQ1 2021 | Mar 31, 2021 | $3.37B | -27.6% |
| Q3 FY2021CQ4 2020 | Dec 31, 2020 | $1.21B | – |
| Q2 FY2021CQ3 2020 | Sep 30, 2020 | $1.02B | – |
| Q1 FY2021CQ2 2020 | Jun 30, 2020 | -$1.06B | – |
| Q4 FY2020CQ1 2020 | Mar 31, 2020 | $4.65B | +19.5% |
| Q3 FY2020CQ4 2019 | Dec 31, 2019 | -$121.00M | – |
| Q2 FY2020CQ3 2019 | Sep 30, 2019 | -$108.00M | -107.8% |
| Q1 FY2020CQ2 2019 | Jun 30, 2019 | -$51.00M | – |
| Q4 FY2019CQ1 2019 | Mar 31, 2019 | $3.90B | +28.8% |
| Q3 FY2019CQ4 2018 | Dec 31, 2018 | -$177.00M | – |
| Q2 FY2019CQ3 2018 | Sep 30, 2018 | $1.38B | +130.6% |
| Q1 FY2019CQ2 2018 | Jun 30, 2018 | -$1.06B | -243.2% |
| Q4 FY2018CQ1 2018 | Mar 31, 2018 | $3.02B | +110.7% |
| Q3 FY2018CQ4 2017 | Dec 31, 2017 | -$18.00M | -104.7% |
| Q2 FY2018CQ3 2017 | Sep 30, 2017 | $598.00M | -44.1% |
| Q1 FY2018CQ2 2017 | Jun 30, 2017 | $741.00M | – |
| Q4 FY2017CQ1 2017 | Mar 31, 2017 | $1.44B | – |
| Q3 FY2017CQ4 2016 | Dec 31, 2016 | $381.00M | – |
| Q2 FY2017CQ3 2016 | Sep 30, 2016 | $1.07B | – |
See a number that looks wrong?